Logo-jcvtr

J Cardiovasc Thorac Res. 2017;9(4): 209-214. doi: 10.15171/jcvtr.2017.36
PMID: 29391934        PMCID: PMC5787333

Original Article

Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen

Ahmed Bendary 1 * , Wael Tawfik 1, Mohamed Mahrous 1, Mohamed Salem 1

Cited by CrossRef: 2


1- Shrestha B, Pradhan R, Shrestha P, Bastakoti S. Streptokinaseā€Induced Serum Sickness: A Case Report. Clinical Case Reports. 2024;12(12) [Crossref]
2- Ola-Davies O, Oyagbemi A, Omobowale T, Akande I, Ashafa A. Ameliorative effects of Annona muricata Linn. (Annonaceae) against potassium dichromate-induced hypertension in vivo: involvement of Kim-1/p38 MAPK/Nrf2 signaling. 2019;30(4) [Crossref]
3- Hengstenberg C, Siller-Matula J. Shedding Light on Long-Term Effects of Early Antiplatelet Strategies After Fibrinolytic Treatment in STEMI. Journal of the American College of Cardiology. 2019;73(22):2829 [Crossref]